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Among potential environmental harmful factors, fungi deserve special consideration. 
Their intrinsic ability to actively germinate or infect host tissues might determine a prom-
inent trigger in host defense mechanisms. With the appearance of fungi in evolutionary 
history, other organisms had to evolve strategies to recognize and cope with them. 
Existing controversies around dampness and mold hypersensitivity syndrome (DMHS) 
can be due to the great variability of clinical symptoms but also of possible eliciting 
factors associated with mold and dampness. An hypothesis is presented, where an evo-
lutionary analysis of the different response patterns seen in DMHS is able to explain the 
existing variability of disease patterns. Classical interpretation of immune responses and 
symptoms are addressed within the field of pathophysiology. The presented evolutionary 
analysis seeks for the ultimate causes of the vast array of symptoms in DMHS. Symptoms 
can be interpreted as induced by direct (toxic) actions of spores, mycotoxins, or other 
fungal metabolites, or on the other side by the host-initiated response, which aims to 
counterbalance and fight off potentially deleterious effects or fungal infection. Further, 
individual susceptibility of immune reactions can confer an exaggerated response, and 
magnified symptoms are then explained in terms of immunopathology. IgE-mediated 
allergy fits well in this scenario, where individuals with an atopic predisposition suffer 
from an exaggerated response to mold exposure, but studies addressing why such 
responses have evolved and if they could be advantageous are scarce. Human history 
is plenty of plagues and diseases connected with mold exposure, which could explain 
vulnerability to mold allergy. Likewise, multiorgan symptoms in DMHS are analyzed for its 
possible adaptive role not only in the defense of an active infection, but also as evolved 
mechanisms for avoidance of potentially harmful environments in an evolutionary past 
or present setting.
Keywords: evolution, allergy disease, symptom perception, behavior, ige
introdUCtion
After several decades of research in the field, the systemic health effects of mold exposure still seem 
to be a controversial issue. Several mainly methodological reasons account for this scenario. Fungal 
spores and components, unlike other bioaerosol particles, are more heterogeneous and biologically 
dynamic particles. Scientific advances have provided us with some analytic procedures to estimate 
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the environmental load of fungi by measuring β-glucan or 
N-acetylhexosaminidase (1, 2) and airborne fungal cell frag-
ments (3), and by assessing the presence of mycotoxins in the 
environment or even in human samples (4–6). Further, molecular 
biology is able to detect fungal DNA in human samples or tissues, 
such as in sinus (7). Measurements of fungal cell agents are more 
precise than ocular inspection to detect fungi (1, 8). Nevertheless, 
these possible biomarkers are not being widely used for research; 
epidemiologic studies or the clinical practice and reality is that 
exposure assessments are often based on subjective methods 
(9). In the case of inflammatory markers associated with mold 
exposure and clinical health effects, the difficulty for using them 
arises because these inflammatory markers are frequently unspe-
cific in nature and lack sufficient evidence for causality, whereas 
epidemiologic studies need specific biomarkers of both mold 
exposure and clinical involvement. In the habitual clinical setting, 
the specialist commonly uses only biomarkers of disease and uses 
the clinical history for estimation of exposure to noxious agents. 
In fact, in allergology, the clinical history still represents the most 
important criterion when assessing a patient. Positive tests have 
to be in accordance with a plausible relationship between the 
patient’s complaints and his exposure history in order to avoid 
false-positive associations. These results are not only due to 
possible irrelevant cross-reactivity or methodological issues but 
also because the presence of IgE is not a necessary indicator of 
mold exposure (10). A major problem is on the other side, the 
lack of measurable scientific evidence, when patients and doc-
tors see a plausible correlation of mold exposure and attributed 
health problems without having specific biomarkers of exposure, 
which support the claimed interrelation. Most clinical studies 
have used self-reported symptoms and were based on subjective 
complaints prone to bias and confounders (10). Finally, even if 
IgE could in some instances serve as a valuable biomarker of effect 
as evidenced in mold allergy, a recognition pattern of allergens 
resulting from individual exposure and sensitization will always 
be patient specific, not only because of interindividual’s varying 
exposure histories but also genetically determined constraints of 
recognition of immunogens. The recognition patterns of allergens 
resulting from exposure to complex allergenic sources are always 
patient specific (11).
Figure 1A shows estimates of evidence for the causal relation-
ship between dampness and mold exposure in buildings and 
health effects. It shows that the relationship between dampness 
and mold and respiratory disease is mainly clinical and epide-
miological, and besides IgE as a biomarker of allergy, other 
biomarkers of exposure or specific of mold-induced disease are 
beginning to be recognized only now. This explains that visible 
mold or dampness is frequently assessed as an environmental fac-
tor and in fact correlation with clinical health effects is frequently 
higher than when specific exposure markers have been used in 
distinct settings (12). The presence of visible mold serves as a 
good indicator that the indoor environment is out of balance (13). 
Damp housing conditions are repeatedly reported to be associated 
with respiratory illness both in atopics and in non-atopics and 
both in public and in domestic environments (14–16). In these 
damp housing conditions, there are some indications that mold 
spores were associated with the symptoms (16). Within dampness 
and mold hypersensitivity syndrome (DMHS), the connection 
between mold exposure and allergic respiratory disease belongs 
to the most evident relationships (see below).
Moving from diseases with accepted biomarkers and more 
defined nature of symptoms, such as respiratory allergy, to syn-
dromes or symptoms, which are frequently subjective in nature, 
such as cognitive difficulties, memory loss, or fatigue, compli-
cate the evaluation of cause and effect relationships in DMHS 
(Figure 1B). Therefore, in the last decades, different causal and 
syndromic relationships have the description of “sick building 
syndrome,” “mixed mold mycotoxicosis,” or other environmental 
sensitivities. Even chronic fatigue syndrome or clinical features 
similar to this entity have been connected not only to relevant 
environmental histories of exposure to water-damaged buildings 
but also to the detection of mycotoxins (4). These descriptions 
frequently overlap with other diseases in an autoimmune context.
The study of causality in epidemiology or toxicology is not 
only characterized by difficulties when assessing monocausality 
or multicausality or a specific syndrome or disease. Difficulties 
also arise by the complex mixture of health outcomes with 
exposure to the same suspected agents ranging from frequently 
asymptomatic subjects to clear-cut allergic or non-allergic res-
piratory disease to various accompanying symptoms in several 
systems. Peoples’ responses to factors in their environment vary 
enormously (17). Discrepant symptoms from equally exposed 
subjects can be due to differences in susceptibility in genetically 
determined biochemical and immunological traits and thus these 
are the reasons for contradictory results or negative results in 
clinical studies. There is also a tendency to misinterpret the lack 
of evidence for causation as evidence for lack of a causal relation. 
In this sense, causality criteria can be used to falsely postpone 
public health action under the pretext that the available evidence 
does not fulfill the criteria (18).
Evolutionary medicine is the application of modern evo-
lutionary theory to the understanding of health and disease. It 
searches for evolutionary explanations of disease and symptoms 
as complement to the analysis of the proximate causes of disease 
(pathophysiology). Analyzing the complex relationship between 
mold exposure and health effects by evolutionary theory could 
help to explain the existing controversies and inconsistencies in 
research findings.
I will show that the existing controversies around DMHS due 
to the great variability of clinical symptoms and also of possible 
eliciting factors associated with mold and dampness account 
for the methodological constraints of clinical studies in DMHS 
and eventually to lack of consistent findings if an evolutionary 
approach is not used. An evolutionary analysis of the different 
disease patterns seen in DMHS is able to explain these, mainly 
as an attempt to avoid and defend exposure to potential harmful 
noxious agents.
FUnGi in an eVoLUtionary 
perspeCtiVe
For an evolutionary analysis of DMHS, we should first investigate 
the ecological relationship between humans and molds, the pos-
sible coevolution or absence of coevolution between mold and 
FiGUre 1 | (a,B) Estimates of evidence for a causal relationship between dampness/mold exposure and disease. Whereas detection of IgE is used as a biomarker 
in allergic airway disease and belongs to the highest evidence in dampness and mold hypersensitivity syndrome (DMHS), extra-respiratory symptoms are less 
consistent when analyzed in different epidemiologic studies. PFT, Pulmonary function testing; MMT, Mixed mold mycotoxicosis.
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FiGUre 2 | proposed hypothesis linking exaggerated symptoms due to a more pro-inflammatory status as a consequence of a lack of coevolution 
between most fungi and humans (below), whereas in the case of coevolution between parasites and humans, inflammation is downregulated by 
chronic infection.
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humans, and then analyze the relationship between immune 
features and the explanation of symptoms as possible defense 
mechanisms, not excluding the study of a neurobehavioral 
component.
Fungi and molds are ubiquitous and comprise as much as 25% 
of the world’s biomass and make up to 4–11% of fine particle mass 
in urban and rural air (19). Noteworthy, fungal spores are often 
100–1,000 times more numerous than other bioparticles, such 
as pollen (20). Among potential environmental harmful agents, 
fungi deserve special consideration. This is also true when con-
sidering them as potential infectious agents, as they are microbes 
that can be acquired directly from the environment (21).
Overall, the relationship between humans and fungi denotes 
a paradox. There are only a few thermal dimorph species able to 
infect, persist, and cause disease in healthy hosts (22). Invasive 
fungal infections are rare, and it has been noted that humans and 
other mammals have a remarkable resistance to fungal patho-
gens (22, 23). On the other side, if fungal infection is invasive, 
it is among the most difficult diseases to manage and frequently 
lethal (22).
An evolutionary analysis shows that for most fungi, it is not 
necessary to rely on a life host for propagation. Human mycoses 
are seldom contagious (23). In an evolutionary host–parasite 
relationship as proposed for other infectious agents, such as 
virus, parasites, or bacteria, the outcome of parasite virulence 
depends on how symptoms would affect transmission probability 
(24). Natural selection provides a pressure on microorganisms 
and parasites, which depends on host to host transmission to 
“self-limit” virulence, inducing an equilibrium point of virulence, 
where parasite’s fitness is highest. The absence of a host–parasite 
relationship, such as between most fungi and humans, without 
mechanisms of coevolution, is eventually associated with higher 
pathogenicity. A higher investment in prevention and elimination 
of these potential invaders by the host is therefore to be expected, 
such as an important pro-inflammatory component of the host 
response (Figure 2).
Fungi appeared soon in the evolutionary history of life and 
other organisms had since then to evolve strategies to recognize 
and cope with them. Classical examples of deleterious effects of 
mold or mycotoxins come mainly from the field of alimentary 
toxins, such as neutropenia associated with tricothecenes pro-
duced by Fusarium tricinctum, other immunomodulatory effects 
of fungi or the effect of ergotism throughout human history by 
Claviceps purpurea (25). Another example is the recent discovery 
of fungal cells and hyphae in the tissue of the central nervous 
system of patients with Alzheimer’s disease, which is not found 
in control subjects (26). Other neurodegenerative diseases, such 
as amyothrophic lateral sclerosis or multiple sclerosis, have been 
associated with fungal infection (27, 28). Estimates have shown 
that more people die from fungal infections than from tubercu-
losis or malaria together (29). Modern way of life leads people to 
spend more than 80% of their time indoors, but at least as late as 
in Antiquity (Leviticus), fungal infestation of buildings has also 
been mentioned.
Notwithstanding, fungi could have played an important role 
in selecting for traits able to avoid deleterious effects of fungi, 
mold, and their metabolites. Endothermic and homeothermic 
lifestyle of mammals has been suspected to account for the 
restricted pathogenicity of the vast number of fungal species 
(21). Invasive fungal disease is rare and appears mainly in patients 
BoX 1 | Unnecessary or exaggerated symptoms.
Evolutionary medicine takes into account a trade-off model, where different 
adaptations to changing environments are associated with disease suscepti-
bility. After ruling out that symptoms are produced by direct toxic effect (difficult 
in the clinical practice) and when considering them as a defense mechanism 
by the host, the following items have to be taken into account: frequently, 
symptoms are exaggerated and the defense amplitude is not correlated with 
the necessary response. This can also be due to the smoke detector principle 
with expression of a false alarm, when the cost of expressing a defense is 
low compared to the potential harm it protects against (52). Therefore, it is 
to be expected that the defense reaction is able to produce uncomfortable 
consequences or adverse health effects, not necessarily related to the cur-
rent pathogen avoidance or defense. In our special case, the cost of fungal 
infection with high mortality could explain the often exaggerated symptoms 
and multisystem complaints in DMHS by the intrinsic selection pressure. 
Otherwise not all defense reactions should be considered adaptive now or 
postulated having been adaptive in the evolutionary past. The real potential 
of symptoms in DMHS to have an ongoing adaptive function can only be 
assessed in future studies, when latent infection or subclinical colonization 
by fungi, as well as severe systemic infections or other direct toxic harming 
effects are assessed and patients with similar exposure histories with and 
without MDHS are compared.
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with impaired immune function. But there are also case reports 
describing invasive fungal disease, such as invasive sinusitis or 
rhinosinusitis (30, 31) or craniocerebral aspergillosis of sinonasal 
origin, in immunocompetent patients (32). These data tell us 
that the powerful immune defense system of humans has in fact 
evolved effective mechanisms to avoid ubiquitous fungi to be 
pathogenic in most immune-competent subjects, but the arms 
race between fungi and the immune system of vertebrates is still 
visible.
HypotHesis
How can an evolutionary approach help to disentangle the 
apparent lack of proof for mold- and dampness-associated health 
effects? The following approach is not intended to strengthen the 
evidence of DMHS, but can be helpful to explain inconsistencies 
when analyzing different study results and could be useful to 
the design of future studies. The evolution of causality in epide-
miology has changed over the last century from a monocausal 
approach to a polycausal understanding (33), which should not 
hinder to analyze possible effects of dampness per  se, or mold 
and/or its different disease-causing components, such as volatile 
organic compounds, hyphae, spores, and mycotoxins. But the 
possible drawback in DMHS is that clinical symptoms are vary-
ing in the syndrome and many claimed that often non-specific 
health complaints have been described, ranging from respira-
tory to rheumatic, neurological, systemic, and even behavioral 
symptoms. An evolutionary approach would therefore be most 
helpful by analyzing the effect-side of the cause-effect relationship 
attempting to explain the vast range of symptoms in the context of 
interindividual variability.
I hypothesize that variability in symptoms and susceptibility to 
mold and dampness can be explained by analyzing the relation-
ship between fungi, mold, and humans over evolutionary time, its 
impact on the immune and behavioral system, and the resulting 
visible defense mechanisms as disease. No previous hypothesis 
has been published on the possible evolutionary origins of DMHS, 
as the main focus in studies addressing causality of symptoms 
and disease associated with exposure to water-damaged buildings 
has been the search for proximate causes in a pathophysiological 
evaluation, such as the toxic effects of mycotoxins, the mecha-
nism of hypersensitivity symptoms in IgE-mediated reactions, 
or the analysis of multiorgan complaints. An ultimate causation 
analysis highlights the biological origins of the different response 
patterns, selected over evolutionary timescales because of puta-
tive adaptive values in the past and possible adaptive values in 
the present.
A central evolutionary hypothesis states that symptoms 
associated with mold exposure can be analyzed with respect to 
a possible adaptive function. This does not necessarily mean that 
they are adaptive in a concrete individual but that the diversity 
of response mechanisms and the preponderance of apparently 
exaggerated symptoms could be due to the evolutionary history 
of humans and its relationship with exposure to fungi and their 
metabolites (see also Box 1). Exposure to fungi is not only associ-
ated with unspecific and specific host defense mechanisms but 
probably also with a capacity to induce a more pro-inflammatory 
immune response and lack of anti-inflammatory regulation, 
such as it is known with microorganisms or parasites (Figure 2). 
Further, important disease avoidance mechanisms can explain 
frequent symptoms induced by reflexive or signaling mecha-
nisms, when these are able to inform the individual to avoid 
exposure or re-exposure to a potentially damaging environment. 
This also explains that not only the presence of different molds or 
fungi is able to induce symptoms, but associated factors, such as 
dampness per se, could also induce symptoms. If symptoms are 
mainly due to the host defense arm in the interaction between 
fungi and humans, it also explains interindividual variability in 
defense-associated symptoms or behavioral patterns as well as a 
wide range of possible eliciting factors, which can include olfac-
tory and visual signals.
Besides mold able to infect humans, other pathophysiological 
mechanisms of symptoms or disease can be summarized to be a 
toxic-irritant effect from mold metabolites or the generation of a 
deleterious immune response (34). When considering symptoms, 
these can thus be interpreted to be elicited by a direct damaging 
or toxic effect, by the induction of a defense response by the host 
or both (Figure 3). Figure 3 also shows how tolerance to the same 
agent can be interpreted as a lack of interaction between mold 
and the host, or on the other side, a potentially damaging effect 
is neutralized by mounting a simultaneous defense. The reader 
should be aware that the proposed effects cannot be completely 
differentiated in the real-life situation but individual susceptibil-
ity encountering the same potentially damaging agent can be 
explained.
As can be seen in Figure 1B, scientific evidence for DMHS is 
more difficult to ascertain when symptoms or implicated organs 
do not belong to the respiratory tract and comprise a multiple 
non-respiratory system syndrome, mainly because of lack of a 
robust objective indicator of illness and effect of mold on it. As 
an example of extra-respiratory symptoms, mold exposure to 
Stachybotrys chartarum has been associated with rashes, blurred 
FiGUre 3 | adverse health effects or tolerance to mold exposure 
depend on the relationship between defect and defense. A toxic 
mechanism on the host or its organs can be directly produced by mold and 
be visible as adverse health effect (e.g., by toxins), but symptoms can also be 
elicited by a response of the host (e.g., inflammation) to a mold component. 
Tolerance can be due to a lack of interaction between mold and the host or 
by the neutralization of a possible toxin by the host response (above). Note 
that in the clinical setting, it can be difficult to disentangle every postulated 
mechanism.
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vision, memory loss, headache, fatigue, nausea, balance loss, 
cognitive dysfunction, or even hemorrhage and seizures (35).
In the next sections, I will go through the different mechanisms 
of defense, which include classical immune phenomena, and also 
those produced by neuroendocrine pathways. I will show that 
these mechanisms are not only associated with the well-known 
“purpose” of defending pathogens but also of avoiding them as a 
prevention strategy. It is exactly the variability of mechanisms and 
thus occurrence of symptom complexes of the last feature that 
could explain the lack of consistent findings in clinical studies, if 
the biological meaning of evolved mechanisms and symptoms is 
not taken into account.
deFense and aVoidanCe
If it is true that dangerous fungal infections have influenced our 
evolutionary history, natural selection would have acted on those 
traits, which confer less risk of infection. The overall resistance 
of mammals to fungal disease and the fact that most human sys-
temic fungal disease are opportunistic in nature, and associated 
with important immunodeficiency should explain the existence 
of a vast host defense machinery to prevent infection by these 
organisms. Therefore, reflexive or immune-mediated symptoms 
associated with mold exposure before infection should be inter-
preted as a means to avoid the costly defense mechanisms or even 
reduced fitness and death, which would arise when the pathogen 
has already entered the host.
The first line of defense is anatomical, and mechanisms, such 
as muco-ciliary clearance, represent a first strategy for removal 
of airborne fungi (20). We should also include the microflora 
of saprophytic microorganisms, which compete with potential 
intruders to a local ecologic equilibrium (36). Further defense 
lines are the innate and the adaptive immune system [reviewed 
in Ref. (37)]. Symptoms can be induced by the inflammatory 
reaction, but can also arise by reflexive mechanisms. The inflam-
matory mediators induced by an immune response to offending 
agents are further able to provoke a sickness behavior, such as 
sleepiness, depression, apathy, and social withdrawal (38).
The defense mechanisms are not necessarily directed only 
against the dangerous spore or invading hyphae. Besides the com-
mented preventive disease avoidance mechanisms, signals associ-
ated with these potential noxious agents can be toxins, secreted 
proteins, or even proteins or other signals associated in time or 
space. Some examples of host responses to indirect non-offending 
signals associated with dangerous factors are the following: Profet 
hypothesized that IgE against specific non-offending proteins 
could be elicited in order to avoid entry of potentially damag-
ing toxins, when these are linked (39). Lappé hypothesized that 
IgE production against mites could have evolved sometime after 
the agrarian revolution as a tocsin or warning that a person is 
in an environment conductive to mold-related illness, because 
moldy, storage crops require humidity, and humidity encourages 
infestation with storage mites (40). Toxins in contaminated food 
can be the best sign of a pathogen’s presence (41). Extending the 
idea, airborne mold-associated particles, such as volatile organic 
compounds, can serve as a signals of potentially harmful invad-
ers in the environment and all human sensory organs can be 
implicated in different mechanisms of disease avoidance. Thus, it 
could be summarized that defense mechanism could be initiated 
when certain signals are associated with a particular probability 
of exposure to harming fungi or molds.
Immune phenomena inducing defense against noxious 
agents can be induced by different means, but the final effector 
mechanisms are accompanied by inflammation. In fact, the 
mechanisms of non-allergic asthma (without IgE production) 
result frequently from similar inflammatory changes, and the 
implication of other immunoglobulin isotypes cannot be ruled 
out (42). Likewise fungal species induce inflammatory processes 
and histamine release without implication of an IgE-mediated 
mechanism (43).
The immunologic Th2 response to parasites has been associ-
ated with the development of effector mechanisms that help to 
clear host organs from multicellular parasites. Mast cells, but 
also eosinophils and other immune cells, contribute to the 
release of mediators that eventually lead to a “weep and sweep” 
response, which is characteristic of many intestinal helminth 
infections, rendering an inhospitable environment for the 
helminth parasite (44).
On the other side, in the case of Aspergillus, and also other 
fungi, the production of aTh1 immune response appears to be 
protective, whereas Th2 responses is not (37). Achieving a balance 
between Th1 and Th2 cytokines may be important for optimal 
antifungal protection while minimizing immune-mediated dam-
age. In general, a Th1 response is required for clearance of a fungal 
infection, while Th2 immunity usually results in susceptibility to 
infection or allergic responses (45). Th1 and Th17 are the princi-
pal T helper subsets shown to contribute to protective immunity 
to several pathogenic fungi (46).
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Visual signs or specific odors allow us to avoid putrid food, a 
behavior that is able to save lives and for some substances, such 
as geosmin, an extremely high sensitivity of the human nose has 
been detected (47). Disease avoidance mechanisms taken by an 
animal are aimed at reducing its chances of becoming infected 
with pathogens or parasites.
A classical infection-avoidance behavior is disgust, a possible 
pan-mammalian adaptation, where emesis is associated with a 
protective response and existence of a clear association between 
signal and disease (41, 48). Disgust sensitivity varies between 
individuals as a trait and within individuals by their state and 
also through individual learning or imitation (48). At the cost of 
a possibly high rate of false-positive detections, this mechanism 
survived by evolution detecting pathogen threats, mainly in food 
and besides bacterial contamination by sensing visual, olfactory, 
or gustatory signals includes foodborne disease by fungi and 
associated mycotoxins. Another issue is that repeated exposures 
to certain kinds of danger may adaptively lower response thresh-
olds (49) and thus explain interindividual variability of symptoms 
due to different past exposure histories.
Given the choice, we prefer clean, dry environments in which 
to live (50). The explanation comes from extension of the disgust 
mechanism, and also from learning behavior. Unhealthy envi-
ronments are thus able to elicit symptoms caused by reflexive or 
learned mechanisms, which in turn help to avoid this environment 
and a higher probability of disease by environmentally acquired 
pathogens. On the other side, an exaggerated or unnecessary 
immune response or reflexive behavior leads to unpleasant symp-
toms and disease. Like inflammatory disease being the trade-off 
for a powerful immune response against pathogens, also behav-
ioral mechanisms have the potential for producing consequences 
unrelated to pathogen avoidance. Obvious difficulties arise when 
studying and assessing these often subjective symptoms with lack 
of measurable specific markers. The role of mold components, 
such as mycotoxins, in diseases caused by fungi growing inside 
buildings is controversial (51). The above reasoning could explain 
the controversial findings when assessing the health effects of 
mold components and therefore much of the symptoms could 
possibly be explained by an exaggerated host response and not 
by a direct toxic effect.
In the clinical practice, one of the problems associated with the 
study of these symptoms in relationship with claimed mold expo-
sure is that patients see an attempt by physicians to take refuge in 
a psychiatric label (17). Further, some behavioral responses could 
be elicited by learned or conditioning reflexes by the attempt to 
avoid repeated unpleasant situations. But an evolutionary per-
spective can also help here to interpret psychological shortcuts or 
signals. Again, the lack of both widely accepted specific biomark-
ers and the specificity of symptoms accounts for the controversy 
in this study field. Whereas a classical immune reaction serves 
to avoid invasion or multiplication, when fungi and mold have 
already gained access to some organ, neuropsychiatric symptoms 
could be interpreted as a behavioral response “intended” to avoid 
further environmental exposure or as signals for the need for 
help and treatment to potential helpers. After ruling out direct 
neurotoxic effects accounting for the presence of these symptoms, 
some of them, such as social withdrawal or depression, can be 
discernible to other group members and could have evolved as 
defense mechanisms (38). An evolutionary-based interpretation 
of psychiatric disease is difficult, but in DMHS these symptoms, if 
present, are frequently accompanying more classical, measurable 
respiratory symptoms. Thus, suffering subjects, if they are aware 
of the relationship between possible exposure and symptoms, will 
try to avoid this exposure.
It is thus clear that humans, like other organisms, must have 
evolved mechanisms not only to cope with invading harmful 
pathogens, but also to avoid or reduce exposure to them in order 
to prevent them to gain entry into vital systems (50, 52).
aLLerGiC and non-aLLerGiC 
respiratory disease
Sneezing and cough, and also airway mucus production, are 
typical in respiratory infection. Virus infections damage air-
way epithelium producing part of the symptoms, but the local 
inflammatory response by the host produces the other part of the 
symptoms. As respiratory infections are transmitted by sneezing 
or by droplets, a classical way to analyze these symptoms in an 
evolutionary perspective is to interpret the induced response as a 
manipulation of the host to aid dispersal of the disease and/or a 
defense by the host to eliminate the disease (53).
But cough and other reflexive symptoms being unpleasant 
have a further explanation, in that their aversiveness motivates 
escape and future avoidance of situations that could have caused 
the response (54).
Among inhalant allergens and compared to other common 
allergens, such as house dust mites, dander, or pollen, the role 
of fungi in allergic airway disease has always been more contro-
versial. For example, it has been asserted that fungal allergens 
in research and molecular allergology are largely neglected (55). 
This is due to a still limited power of diagnostic tools compared 
to other aeroallergens. The fungus kingdom is especially difficult 
for assessing allergy due to incompletely validated standardized 
extracts, difficulties in the production of allergenic molecules, and 
also the presence of phylogenetically conserved cross-reactive 
allergens (11). Commercially available extracts used for diagnosis 
and assessment of mold allergies do not cover the majority of 
molds identified in the indoor air of buildings with moisture 
problems (56). There are however epidemiologic data that con-
sistently support the relationship between fungal exposure and 
allergic airway disease [reviewed in Ref. (14)].
Chronic mold exposure at home, work, or school are associ-
ated with increased upper and lower respiratory symptoms (57). 
Commonly, the presence of specific IgE or positive SPT highlight 
an allergen-dependent pathway, but there is also evidence that 
mold is associated with respiratory symptoms, such as asthma in 
an allergen-independent manner. In fact, it has been stated that 
most common inflammatory reactions associated with fungi are 
non-allergic in nature (10, 20). Further, there is some evidence 
of a higher susceptibility to infectious disease with wheezing and 
non-wheezing lower respiratory tract illness, such as pneumonia, 
croup, bronchitis, or bronchiolitis (58). As chronic mold exposure 
is able to alter the immune response and could adversely affect 
the ability to combat infections (10), the trade-off model would 
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suggest an adjustment of investment of costs of the immune 
system (59).
Up to 24% of the population has IgE antibodies or positive 
skin tests to common inhalant molds (55, 60, 61). Furthermore, 
when analyzing a cohort of subjects with respiratory diseases, 
the prevalence of sensitization is around 19% (61) or up to 44% 
among atopics (55). The incidence of asthma, and also the sever-
ity, has repeatedly been shown to be higher in patients with skin 
sensitivity to common indoor fungi [reviewed in Ref. (62)]. Mold 
exposure as well as dampness has been associated with new onset 
of asthma (63, 64). Mold allergy and mold-associated respiratory 
disease have been shown to be linked with both outdoor and indoor 
exposures (9). Meta-analyses have shown building dampness and 
mold to be associated with approximately 30–50% increases in 
various respiratory and asthma-related health outcomes (65). 
There are also other immunologic diseases produced by mold, 
such as hypersensitivity pneumonitis, but due to the paucity of 
generally available biomarkers, a significant emphasis has been 
placed mainly on type I allergy and asthma and less emphasis has 
been placed on other immunopathological mechanisms involved 
in the pathogenesis of type II–IV allergy (66).
Another issue is that mold exposure may increase sensitivity 
to commonly inhaled microorganisms and inert substances and 
increase the risk of secondary infections (67).
Respiratory symptoms in asthma include coughing, wheezing, 
chest tightness, and shortness of breath. Bronchial inflammation 
induced by allergic and non-allergic mechanisms produces nar-
rowing of the lower airways producing the symptoms. As has 
been said above, this mechanism could have an adaptive origin. 
Bronchial asthma has been the focus of several evolutionary 
analyses. These are mainly based on a rapidly changing environ-
ment and the inflammatory potential of asthma is explained as an 
exaggerated immunopathological response in the context of the 
hygiene hypothesis. It states an increase of chronic inflammatory 
and autoimmune disease, as a consequence of a diminished expo-
sure to infectious agents, symbiotic microorganisms, or parasites, 
which would be necessary for a balance between pro- and anti-
inflammatory forces (68). In the special case of allergy and IgE 
production, an evolutionary perspective gives emphasis to a 
long-lasting history of mammals with IgE-inducing multicellular 
parasites, where chronic infections or stimuli would otherwise 
downregulate damaging effector response (69). Lappé proposed 
the asthmatic response to be a defensive mechanism to avoid 
dangerous mold to gain entry to the lungs. The risk of inhaling 
moist spores would be the selective force in the development of 
asthma (40).
As health effects of mold and dampness on the respiratory tract 
have been evidenced for both allergic and non-allergic patients, 
one possibility is that sensitization is only a marker and a special 
case of an ongoing inflammatory response against mold or fungi 
in genetically susceptible patients. Inflammatory and broncho-
obstructive symptoms obtained by exposure to organic dust also 
produce similar symptoms. Norn concluded that the exposure to 
fungal spores enhances the histamine release triggered by both 
allergic and non-immunologic mechanisms (70, 71). Therefore 
toxic, rather than allergic or similar inflammatory, processes were 
involved (72).
Chronic fungal infection of the respiratory tract can affect 
immunocompromised or immunocompetent patients. There 
is increasing awareness of chronic fungal rhinosinusitis occur-
ring in otherwise healthy hosts (73). Symptoms are not only 
due to local affection, but there are also reports of generalized 
symptoms, such as that in the case of neuro-muscular symptoms 
after infection by several molds and even local trichothecene 
production (74). Frequently there is a previous exposure history 
to water-damaged buildings.
Interestingly, sarcoidosis, a chronic inflammatory pulmonary 
disease of yet unknown origin has been associated not only with 
exposure to fungi, such as in mold-infested buildings, but in vitro 
studies also showed the implication of immune parameters typi-
cally associated with fungal contact, such as dectin-1, TLR2, and 
TLR4 (1, 75–77). This leads to the hypothesis that sarcoidosis 
could be due to an exaggerated inflammatory reaction in geneti-
cally susceptible individuals after mold exposure (75).
Thus, by this perspective, respiratory symptoms could be 
interpreted as a frontline defense against potentially invasive 
fungi and related conditions associated with mold toxicity. 
Symptoms in sick building syndrome may be induced by the total 
biological load in inhaled air through a combination of toxic and 
immunological responses (78), and this idea can be applied for 
DMHS.
eXtra-respiratory syMptoMs in 
dMHs
For symptoms associated with mold or mold-associated envi-
ronment, different partially overlapping syndromes have been 
proposed. But mold is one of the possible causes in sick build-
ing syndrome. The WHO has classified the reported symptoms 
into broad categories, including: mucous membrane irritation 
(eye, nose, and throat irritation), neurotoxic effects (headaches, 
fatigue, and irritability), asthma and asthma-like symptoms (chest 
tightness and wheezing), skin dryness and irritation, gastrointes-
tinal complaints, and more (79). The definition of mixed mold 
mycotoxicosis has been suggested for a wide range of multiorgan 
symptoms, including upper and lower respiratory symptoms, 
headache, dizziness, visual changes, cognitive impairment, or 
emotional dysregulation in patients with a history of exposure 
to mixed colonies of molds and their associated mycotoxins (80).
In our analysis, we can divide extra-respiratory symptoms 
into two broad categories: the first includes symptoms that are 
produced by an inflammatory reaction and the second can be 
seen as neurobehavioral.
Like in autoimmune disease, systemic inflammation can 
affect different organs, and therefore several descriptions of 
DMHS-associated disease include rheumatic or neurological 
symptoms (81, 82). The term chronic inflammatory response 
syndrome has been coined by Shoemaker et  al. for multiorgan 
symptoms following exposure to the interior environment of a 
water-damaged building with resident toxigenic organisms, and 
their associated compounds (83). Otherwise, the interpretation 
of appearance of autoimmune disease in a modern environment 
with an over-reacting immune system and eventually exaggerated 
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or unnecessary symptoms is similar to the application of the 
hygiene hypothesis in the field of allergy (68).
Likewise, DMHS can include symptoms in the field of psychol-
ogy or psychiatry. In a study involving patients with exposure to 
mixed colonies of mold and their associated mycotoxins, stress-
induced disturbances ranged from depression, affective loss of 
control, to cognitive disorders (80). Memory loss, headache, 
fatigue, balance loss, or cognitive dysfunction is also complained 
by patients with mold-associated sick building syndrome (51) 
and holds also for molds as the postulated cause. Thrasher et al. 
reported on a family, whose five members developed symptoms 
consistent with myalgic encephalitis–chronic fatigue syndrome 
after exposure to molds and mycotoxins in a water-damaged 
home (84).
Interestingly, the term “behavioral immune system” has been 
coined having triggering psychological responses that are adap-
tive for disease avoidance (85). Infection-avoidance behavior 
concerns actions taken by an animal to reduce its chances of 
becoming infected with pathogens or parasites. In fact, symptoms 
such as sneezing, diarrhea, and emesis are not only induced by 
immune reaction, as they can also be interpreted as a behavioral 
response (50). Symptoms are thus a response to environmental 
signals associated with some danger and can be seen as a system 
to motivate escape from and avoidance of situations that harm 
fitness (52).
The presence of multiorgan symptoms, which are frequently 
unspecific, and the fact that cause and health effect relationships 
is difficult to assess or prove, can now be assessed with a differ-
ent perspective, where exaggerated or apparently unnecessary 
symptoms can help the patient to avoid potentially damaging 
environments.
ConCLUsion
The presented evolutionary analysis of DMHS shows evidence 
that the relationship between fungi, mold, and humans has pro-
vided us over eons of time with important defense mechanisms, 
without these we would not have survived as a species. Innate and 
adaptive immune defense mechanisms as well as a neuroendo-
crine system aimed at avoiding contact with potentially harmful 
fungi have a great interindividual variability, but display a mainly 
pro-inflammatory or exaggerated potential in those patients suf-
fering from DMHS.
I show some evidence that symptoms and disease in DMHS 
are associated with an elevated inflammatory status, but the 
observed respiratory and extra-respiratory syndromes are elicited 
by different mechanisms, ranging from IgE-mediated allergy to 
multisystem, autoimmune phenomena, as well as neurobehav-
ioral components. Inflammatory markers have already been 
associated with fungal exposure, but the association can be two 
sided. It seems plausible to think that mold exposure induces an 
inflammatory reaction, but it could also be the other way round, 
in that genetically susceptible individuals with a higher pro-
inflammatory profile due to their evolutionary past, will respond 
to lower threshold of mold and dampness exposure. Like women 
being generally more prone to most autoimmune diseases as a 
trade-off to a higher inflammatory potential to combat infectious 
disease, women do not only suffer more often form sick building 
syndrome but also display higher mold-specific IgG-antibodies 
than men (86, 87). If the hypothesis is true that MHSD is a trade-
off to avoid or defend potential invasive or dangerous pathogens, 
these individuals should have a lower probability of invasive 
fungal disease. As has been said, fungal systemic infection in 
humans is rare, but future epidemiologic studies could evaluate 
those patients, who are at risk to acquire fungal disease and search 
not only for an exposure history but also for symptoms or lack of 
symptoms associated with DMHS.
On the other side, there is a small number of fungi that are able 
to colonize without infection in humans, such as Aspergillus or to 
persist in a latent state, others behave with lifelong dormant infec-
tions, such as Cryptococcus or Histoplasma capsulatum (37). With 
the increasing availability of biomarkers for exposure to molds 
or mold components, such as mycotoxins, but also for presence 
of fungi in human samples, clinical studies could now assess the 
frequency of clinical but also subclinical colonization with these 
fungi in patients with a history of DMHS compared to those with 
similar exposure history and no evidence of fungal colonization. 
In this case, if symptoms in patients with DMHS have an ongoing 
adaptive value, these patients should have a lower frequency of 
colonization or latent infection.
What is clear is that adverse health effects of mold exposure 
should prompt not only a search for the cause, but mainly lead 
to improve indoor environment quality, which will potentially 
benefit many more people than the individual identified with 
these health claims.
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